Dioscin alleviates oxidative stress damage in MTX-AKI by directly targeting the expression of miR-145–5p in Sirt5 and modulating the expression levels of SOD1, Nrf2, GST, HO-1, GCLC, and NQO1 (Li et al., 2021). Here, NFE2L2 is linked to acute kidney injury.